µÚËľüÒ½´óѧ1998ÄêÃâÒßѧ£¨²©Ê¿£© U^ecg{
dK5|tWJX
£¨ÃâÒßѧרҵºÍרҵ»ù´¡£© H\zV/1~Y
Ò».Ãû´Ê½âÊÍ£¨Ã¿Ìâ3·Ö£¬¹²45·Ö£© gCVgL]jj(
1.Co-stimulators (or co-stimulating molecules) aCq ) hR
2.NK-kB vS!%!-F
3.Immunoglobulin superfamily E3):8>R;1
4.antigen-presenting cell (APC) ]dx6E6A,
5.death domain B.e3IM0
6.CCR and CXCR 3X0"</G6
7.Lectin (or mitogen) 4\cJ}p}LZ{
8.Clusters of differentiation, CD) )}
I>"n
9.B7 family P6n9yJ$,cb
10.Cytotoxic T lymphocyte, CTL) m0: IFE($
11.IL-15 and IL-15 receptor (IL-15R) W[+=_B
12.MHC restriction 1ZUmMa1(
13.Affinity-chromatography *A2D}X3
s
14.Cyctosprin A, CsA Gu3# y"a>
15.Antibody-dependent cell-mediated cytotoxicity, ADCC) h!vq~g
¶þ.ÎÊ´ðÌ⣨ÿÌâ10·Ö£¬¹²30·Ö£© j9V*f
HK
1.ºÎΪTh1ºÍ Th2ÑÇȺ£¿ÈçºÎ¼ì²â£¿ÔÚÁÙ´²ÉÏÓкÎÒâÒ壿 aBBTcN%'
2.ÊÔÊöÃâÒßÇòµ°°×£¨Ig£©µÄ½á¹¹Ó빦ÄܵĹØÏµ¡£ yX-h|Cr"
3.ÊԱȽÏTϸ°ûÊÜÌ壨TCR/CD3£©ÓëBϸ°ûÊÜÌ壨BCR£©µÄ×é³É¡¢á¹¹¼°Æäʶ±?¿¹ÔµÄÌØµã¡£ 7a,/DI2o
Èý.Ñ¡ÔñÎÊ´ðÌ⣨¸÷רҵ¿¼ÉúÖ»´ðÒ»µÀ±¾×¨ÒµÊÔÌ⣬25·Ö£© !|G 8b'
ÃâÒßѧרҵ£º "kS(b4^
1.ÊÔÊöB7/CD28, CTLA-4£¬CD40/CD40L£¬LFA-1/ICAM-1£¬CD2/LFA-3µÄ½á¹¹¡¢·Ö²¼ÒÔ¼°Ï໥×÷Óúó½éµ¼µÄÖ÷ÒªÉúÎïѧ¹¦ÄÜ¡£ 8Pkw'.r
Ïû»¯ÄÚ¿Æ£º jjT|@\-u
2.Ö×Áö¿¹Ô·ÖΪÄļ¸Àࣿ»úÌ忹Ö×ÁöÃâÒßÖ÷ÒªÓÐÄÄЩÒòËØ£¨»úÖÆ£©£¿¼òÊöÌá¸ß¿¹Ö×ÁöÃâÒßÑо¿µÄÂԲߡ£ h#Z5vH
ѪҺ²¡Ñ§×¨Òµ£º d0b`qk @4
3.ºÎΪ°×Ѫ²¡µÄÃâÒßѧ·ÖÐÍ£¿ºÎÎªÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£©£¿GVHR·¢ÉúµÄÖ÷ÒªÔÒò£¨Ìõ¼þ£©ÊÇʲô£¿